Macelignan: A New Modulator of P-Glycoprotein in Multidrug-Resistant Cancer Cells
Authors:
- 25 June 2009
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 61 (4) , 538-543
Abstract
The effect of macelignan, a phytoestrogen, on P-gp function was investigated using multidrug resistant cancer cells overexpressing P-gp (NCI/ADR-RES) and the fluorescent P-gp substrates, daunorubicin and rhodamine 123. Macelignan (40 μM) increased the cellular accumulation of daunorubicin by approximately threefold in NCI/ADR-RES cells, whereas it did not alter the cellular accumulation of daunorubicin in MCF-7/sensitive cells. Similarly, the presence of macelignan also enhanced significantly (P < 0.05) the cellular accumulation of rhodamine 123 in a concentration-dependent manner in NCI/ADR-RES cells. Furthermore, cancer cells were more susceptible to the cytotoxicity of vinblastine, a P-gp substrate, in the presence of macelignan. Those results suggest that macelignan has inhibitory effects on P-gp mediated cellular efflux. However, P-gp activity did not affect the cellular accumulation of macelignan itself. Taken all together, macelignan was identified as a novel inhibitor of P-gp activity and may be a promising lead compound for the rational design of more efficacious drugs to reverse multidrug resistance in cancer.Keywords
This publication has 22 references indexed in Scilit:
- Chemoprevention of Prostate Cancer through Dietary Agents: Progress and PromiseCancer Epidemiology, Biomarkers & Prevention, 2007
- Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutansPhytomedicine, 2006
- An update on bioactive plant lignansNatural Product Reports, 2005
- Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cellsBiochemical and Biophysical Research Communications, 2005
- Dietary Lignans: Potential Role in Cancer PreventionNutrition and Cancer, 2005
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- Effects of the Flavonoids Biochanin A, Morin, Phloretin, and Silymarin on P-Glycoprotein-Mediated TransportThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Recent advances in the discovery of flavonoids and analogs with high‐affinity binding to P‐glycoprotein responsible for cancer cell multidrug resistanceMedicinal Research Reviews, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- The structure of macelignan from Myristica fragransPhytochemistry, 1987